Table 2.

Logistic Regression Analysis for the Association Between Serum NGAL Levels and CVD History on Admission in Patients with CHD

Variables	Model 1	Model 2	Model 3
Serum NGAL level
Quartile 1 (low)	1.000 (ref.)	1.000 (ref.)	1.000 (ref.)
Quartile 2	1.47 (1.14–2.43)	1.45 (1.12–2.39)	1.43 (1.10–2.35)
Quartile 3	1.89 (1.31–3.52)	1.84 (1.27–3.46)	1.81 (1.25–3.44)
Quartile 4 (high)	2.46 (1.65–4.67)	2.43 (1.63–4.63)	2.41 (1.60–4.59)
P-trend	<0.001	<0.001	<0.001

Notes: Model 1: Adjusted for age, gender and BMI. Model 2: Adjusted for age, gender, BMI, smoker, drinker, exercise regularly, diabetes mellitus, BP, preserved LVEF and medications. Model 3: Adjusted for age, gender, BMI, smoker, drinker, exercise regularly, diabetes mellitus, BP, preserved LVEF and medications and laboratory measurements.

Abbreviations: NGAL, neutrophil gelatinase-associated lipocalin; CVD, cardiovascular disease; CHD, coronary heart disease; BMI, body mass index; BP, blood pressure; LVEF, left ventricular ejection fraction.